Genpact, a firm that manages business processes for companies worldwide, announced terns for its IPO Monday. The company plans to sell 35.3 million shares, including 17.7 million shares from insiders, at a proposed price range of $16 to $18. Morgan Stanley, Citi, and JP Morgan are Joint Bookrunners on the deal. The deal is currently expected to price in early August.
